Mild: Cancer is unlikely. Data suggest that only risk of non-melanoma skin cancer is slightly increased from remicade (infliximab). Most common side effects are common infections, headache, abdominal pain and infusion reactions. Most are mild.
Answered 12/20/2012
6.1k views
Possibly: Remicade (infliximab) increases infections, including sinus/respiratory infections and severe infections (fungus or tuberculosis.) allergic reaction during infusion is a common side effect. It also increases risk for cancer, particularly lymphomas (3-4x increased risk). Head and neck cancers are increased in people with copd. Really ask your doctor about this so you can balance your risks and benefits.
Answered 6/30/2014
6.1k views
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question